Associate Profesor, Department of Biochemistry, Universidad Central Del Caribe, Bayamón, Puerto Rico
Dr. Michelle M. Martínez Montemayor leads a cancer research and experimental therapeutics laboratory at Universidad Central del Caribe – School of Medicine (UCC). Her research focuses on elucidating potential selective and non-toxic therapies that target aggressive breast cancers. She also studies biomarkers in the most lethal breast cancer subtype, which is inflammatory breast cancer (IBC). Dr. Martínez is interested in establishing collaborations towards increasing IBC education to increase awareness, enforce diagnostic guidelines, and disseminate information in the medical and patient communities. Dr. Martínez completed an Associate Degree at UPR-Bayamón, a Bachelor in Science at UPR-Cayey, a Master in Science at UPR-Mayagüez, a Ph.D. at Michigan State University and two postdocs, one at UPR-Río Piedras in Molecular and Cellular Cognition, and a second one at UCC in cancer biology. She then was recruited as UCC faculty, where her lab has been continuously funded by the National Institutes of Health, the American Institute for Cancer Research, and Susan G. Komen. USDA-NIFA, the PRSTRT, the US Department of Education, and private industry research agreements.
(Updated Sept 26, 2023)